{{Rsnum
|rsid=2280789
|Gene=CCL5
|Chromosome=17
|position=35879999
|Orientation=minus
|GMAF=0.2034
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CCL5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 18.6 | 80.5
| HCB | 14.0 | 41.2 | 44.9
| JPT | 8.8 | 41.6 | 49.6
| YRI | 3.4 | 29.3 | 67.3
| ASW | 1.8 | 42.1 | 56.1
| CHB | 14.0 | 41.2 | 44.9
| CHD | 5.5 | 42.2 | 52.3
| GIH | 1.0 | 20.8 | 78.2
| LWK | 4.5 | 36.4 | 59.1
| MEX | 6.9 | 37.9 | 55.2
| MKK | 3.8 | 18.6 | 77.6
| TSI | 1.0 | 23.5 | 75.5
| HapMapRevision=28
}}{{omim
|desc=CHEMOKINE, CC MOTIF, LIGAND 5; CCL5
|id=187011
|rsnum=2280789
}}

{{PMID Auto
|PMID=21547257
|Title=CCL5/RANTES Gene Polymorphisms in Slavonic Patients with Myocardial Infarction
|OA=1
}}

{{PMID Auto
|PMID=16773571
|Title=Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.
|OA=1
}}

{{PMID Auto
|PMID=17540042
|Title=The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese.
|OA=1
}}

{{PMID Auto
|PMID=17848170
|Title=The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.
|OA=1
}}

{{PMID Auto
|PMID=18217191
|Title=Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study.
}}

{{PMID Auto
|PMID=20041166
|Title=Common genetic variation and the control of HIV-1 in humans.
|OA=1
}}

{{PMID Auto
|PMID=20805685
|Title=Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients.
}}

{{PMID Auto
|PMID=23133602
|Title=Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
|OA=1
}}

{{PMID Auto
|PMID=23207898
|Title=RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}